| Literature DB >> 35677868 |
Almut Zeeck1, Svenja Taubner2, Thorsten C Gablonski3, Inga Lau1, Stephan Zipfel4, Wolfgang Herzog5, Beate Wild5, Hans-Christoph Friederich5, Gaby Resmark4, Katrin Giel4, Martin Teufel6, Markus Burgmer7,8, Andreas Dinkel9, Stephan Herpertz10, Bernd Löwe11, Sefik Tagay12, Jörn von Wietersheim13, Martina De Zwaan14, Max Zettl2, Alexander F Meier1, Armin Hartmann1.
Abstract
Objective: Previous research suggests that patients with anorexia nervosa (AN) show an impaired capacity to mentalize (reflective functioning, RF). RF is discussed as a possible predictor of outcome in psychotherapeutic processes. The study aimed to explore RF in sessions of patients with AN and its association with outcome and type of treatment.Entities:
Keywords: anorexia nervosa; eating disorder; mentalizing; outcome; psychotherapy; reflective functioning; theory of mind
Year: 2022 PMID: 35677868 PMCID: PMC9169151 DOI: 10.3389/fpsyt.2022.814441
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 5.435
Sample characteristics at baseline.
|
| |||
|---|---|---|---|
|
|
|
| |
|
|
|
| |
|
| |||
| Gender (female) | 14 (100%) | 14 (100%) | 28 (100%) |
| Age (years) at intake | 28.34 (10.41) | 27.81 (8.41) | 28.07 (9.29) |
| Marital status | |||
| Single, never married | 11 (78.6%) | 12 (85.7%) | 23 (82.1%) |
| Married, or living as such | 2 (14.3%) | 2 (14.3%) | 4 (14.3%) |
| Separated or divorced | 1 (7.1%) | 0 (0%) | 1 (3.6%) |
|
| |||
| BMI [kg/m2] | 16.64 (1.11) | 16.36 (0.96) | 16.50 (1.02) |
| AN-subtypes | |||
| Binge-Purge | 3 (21.4%) | 6 (42.9%) | 9 (32.1%) |
| Restrictive | 11 (78.6%) | 8 (57.1%) | 19 (67.9%) |
| Duration of illness | |||
| ≤ 6 years | 8 (57.1%) | 11 (78.6%) | 19 (67.9%) |
| > 6 years | 6 (42.9%) | 3 (21.4%) | 9 (32.1%) |
| Co-morbid disorders (DSM IV) | |||
| Affective disorder | 2 (14.3%) | 1 (7.1%) | 3 (10.7%) |
| Anxiety disorder | 4 (28.6%) | 3 (21.4%) | 7 (25.0%) |
| Somatoform disorder | 2 (14.3%) | 0 (0%) | 2 (7.1%) |
| Mean total EDI-2-Score | 258.23 (55.90) | 257.56 (53.38) | 257.92 (53.64) |
CBT-E, enhanced cognitive-behavior therapy; FPT, focal psychodynamic therapy; n, sample size; BMI, body mass index; AN, anorexia nervosa; EDI-2, eating disorder inventory-2.
In-session RF over time by treatment arm (outcome).
|
|
|
|
|
|
|---|---|---|---|---|
| CBT | 14 | 2.74 (0.58) | 2.37 (0.51) | 2.71 (1.05) |
| FPT | 14 | 3.38 (0.58) | 3.47 (0.94) | 2.96 (1.05) |
| (–) | 12 | 3.18 (0.84) | 2.85 (0.97) | 2.51 (1.09) |
| (+) | 16 | 2.96 (0.47) | 2.97 (0.92) | 3.08 (0.96) |
| CBT(-) | 7 | 2.73 (0.71) | 2.31 (0.36) | 2.38 (1.01) |
| CBT(+) | 7 | 2.74 (0.47) | 2.44 (0.65) | 3.05 (1.07) |
| FPT(–) | 5 | 3.82 (0.59) | 3.61 (1.09) | 2.71 (1.29) |
| FPT(+) | 9 | 3.13 (0.43) | 3.40 (0.92) | 3.11 (0.95) |
RF, reflective functioning; T.
Mixed models.
|
| |||||
|---|---|---|---|---|---|
|
| |||||
|
|
|
|
|
| |
| CaseID | Intercept | 0.4018 | 0.6339 | ||
| Phase_123 | 0.1561 | 0.3951 | −0.61 | ||
| Residual | 0.2759 | 0.5253 | |||
|
|
|
|
|
|
|
| Intercept | 3.164 | 0.193 | 27.0001 | 16.37 | 0.0001 |
| Phase_123 | −0.1109 | 0.103 | 27.0001 | −1.08 | 0.2890 |
| LME4 formula: RF ~ Phase_123 + (Phase_123 | CaseID) | |||||
|
| |||||
|
|
|
|
|
|
|
| Intercept | 3.039 | 0.266 | 49.9114 | 11.41 | 0.0000 |
| Phase_123 | −0.231 | 0.168 | 27.6722 | −1.38 | 0.1789 |
| Arm[FPT] | 1.166 | 0.309 | 49.9114 | 3.78 | 0.0004 |
| Outcome[+] | −0.802 | 0.312 | 49.9114 | −2.57 | 0.0132 |
| Outcome[+]:Phase_123a | 0.432 | 0.196 | 27.6722 | 2.20 | 0.0361 |
| Arm[FPT]:Phase_123a | −0.254 | 0.194 | 27.6722 | −1.31 | 0.2023 |
| LME4 formula: | |||||
| RF ~Phase_123 + Arm + Outcome + Outcome*Phase_123 + Arm*Phase_123 + (Phase_123 | CaseID) | |||||
| aEstimates of interaction effects of Group(outcome or arm) with time (phase_123) = Difference of slopes | |||||
|
| |||||
|
|
|
|
|
|
|
| Intercept | 3.168 | 0.249 | 51.4897 | 12.751 | 0.0000 |
| Phase_123 | −0.337 | 0.149 | 28.1903 | −2.267 | 0.0313 |
| Outcome[+] | −0.757 | 0.312 | 44.8619 | −2.428 | 0.0193 |
| Arm[FPT] | 0.856 | 0.197 | 29.6488 | 4.354 | 0.0001 |
| Outcome[+]:Phase_123 | 0.395 | 0.197 | 28.1903 | 2.011 | 0.0540 |
| b Omitting the interaction effect of Phase_123 and outcome (not significant in Model 2a) | |||||
| LME4 formula: RF ~Phase_123 + Arm + Outcome + Outcome*Phase_123 + (Phase_123 | CaseID) | |||||
R-squares: Fixed effects only R.
Figure 1RF casewise over treatment physe by treatment arm and outcome.
Comparison of models.
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|
| Model 1 | 5 | 203.1 | 215.25 | 215.25 | 193.1 | |||
| Model 2b | 9 | 190.81 | 212.69 | −86.406 | 172.81 | 19.096 | 3 | 0.0003 |
Npar, number of parameters; AIC, Akaike's information criterion; BIC, Bayesian information criterion, logLik, log flikeliness.
Correlations of RF with depression, alliance, and BMI.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
| ||
| Depression | As column | 0.14 | – | 0.04 |
| HAQ-Relation | As column | −0.26 | −0.15 | 0.04 |
| BMI | As column | −0.26 | 0.15 | 0.44 |
| Change of BMI | T1 → T2 | 0.16 | 0.13 |
|
| T2 → T3 | −0.18 | 0.03 | 0.05 | |
RF, reflective functioning; T1, early phase; T2, middle phase; T3, end of treatment; Depression, PHQ-9 score; HAQ relation, Helping Alliance Questionnaire, factor measuring the quality of the relation; Change of BMI, BMI difference T2 – T1 or T3 – T2, positive values in case of weight gain; .